'Halftime Report' Traders Shares Their Thoughts On Pfizer, Ethereum And More

On CNBC's "Fast Money Halftime Report," Tiffany McGhee said Pfizer Inc. PFE is not making crazy money from the COVID-19 vaccine, but the company has been researching COVID-19 type of vaccines for years and the pandemic allowed it to focus more on the research and learn about these types of diseases. She continues to hold the stock and she would look for opportunities to buy.

Ethereum ETH/USD is a beautiful play for the crypto space and it's the most useful crypto out there, said Jon Najarian.

Josh Brown said the P/E ratio is not very useful for the financials because they're more likely to be valued on the price-to-book ratio. In the space, he is looking for the current book value and what is the historic P/B.

If the bank is trading with a discount, he would look for reasons and he would ask himself are these problems fixable. Brown also compares the P/B ratio for different banks in the space.

Loading...
Loading...
PFE Logo
PFEPfizer Inc
$23.87-0.04%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
28.17
Growth
32.30
Quality
65.98
Value
31.75
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...